Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Corrigendum: "High-Resolution Spectral Domain-Optical Coherence Tomography in Multiple Sclerosis, Part II - The Total Macular Volume. The First Follow-Up Study Over 2 Years".
Predictors of driving in individuals with relapsing-remitting multiple sclerosis.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Identifying and treating pain caused by MS.
The safety risks of innovation: the FDA's Expedited Drug Development Pathway.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
Symptomatic therapy in multiple sclerosis: the role of cannabinoids in treating spasticity.
NMR and pattern recognition methods in metabolomics: From data acquisition to biomarker discovery: A review.
Emerging tumefactive multiple sclerosis after switching therapy from natalizumab to fingolimod.
Diffusion tensor imaging in the human spinal cord: development, limitations, and clinical applications.
Evaluation of the effects of reflexology on quality of life and symptomatic relief in multiple sclerosis patients with moderate to severe disability; a pilot study.
Imaging Cortical Damage and Dysfunction in Multiple Sclerosis.
Heme oxygenase-1 expression in peripheral blood mononuclear cells correlates with disease activity in multiple sclerosis.
White matter tract abnormalities are associated with cognitive dysfunction in secondary progressive multiple sclerosis.
Cognitive impairment among different clinical courses of multiple sclerosis.
Syringomyelia coexisting with guillain-barre syndrome.
Oropharyngeal dysphagia in patients with multiple sclerosis: do the disease classification scales reflect dysphagia severity?
Multiple sclerosis and herpesvirus interaction.
Raltegravir with optimized background therapy for resistant HIV-1 infection.
Analysis of polymorphisms in RIG-I-like receptor genes in German multiple sclerosis patients.
Neuroendocrine Responses to Transvascular Autonomic Modulation: A Modified Balloon Angioplasty in Multiple Sclerosis Patients.
Multiple sclerosis patient-derived CSF induces transcriptional changes in proliferating oligodendrocyte progenitors.
Polymorphisms of the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis.
Multimodal Quantitative MR Imaging of the Thalamus in Multiple Sclerosis and Neuromyelitis Optica.
Use and acceptance of electronic communication by patients with multiple sclerosis: a multicenter questionnaire study.
Pages
« first
‹ previous
…
333
334
335
336
337
338
339
340
341
…
next ›
last »